MedPath

Clinical study on glycemic excursion improvements with a fixed mitiglinide / voglibose combination in patients with type 2 diabetic mellitus(T2DM) - research into glycemic excursion-improving mechanisms

Not Applicable
Conditions
T2DM
Registration Number
JPRN-UMIN000010409
Lead Sponsor
Yuri Ono Clinic, Diabetes, Internal Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients to whom [Contraindications] in labeling for the combination apply 2)Any others who the principal investigator deems unsuitable as subjects, in consideration of any [Special caution needed] in labeling for the combination

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy endpoints are various metabolic parameter measures as well as changes from baseline and their AUC before and after 4-weeks treatment with the combination, and over 120 minutes after meals in the morning, afternoon and evening meals
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath